HopeStage
Back to all studies
RecruitingNCT03495024

Varenicline study for smoking cessation in schizophrenia

About this titleRead the official source — NCT03495024
Medication studyAges 18–75United States
The study in practice

Understand this study

Who could participate?

This study is for people with schizophrenia. Listed age limits: 18 years to 75 years. Other eligibility criteria apply.

Listed locations
PhiladelphiaSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: January 1, 2019
Recruitment status
Recruiting
Enrollment listed in the registry
10
Sponsor
Corporal Michael J. Crescenz VA Medical Center
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 75 Years
Official registry ID
NCT03495024
Official title
Show the full official title

Effect of Varenicline on Smoking Cessation in Patients With Schizophrenia: Evaluation of Antipsychotic Drug-Induced Neurological Symptoms as Correlates of Response

Recruitment & locations

Currently recruiting

Philadelphia

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Corporal Michael J. Crescenz VA Medical Center, a hospital or academic medical center.

Does this study involve medication?

Yes. The study involves medication, including Varenicline.

Who can participate?

This study is for people with schizophrenia. Listed age limits: 18 years to 75 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies